Clinical Trial Update: Maximal Dose of Angiotensin Converting Enzyme (ACE) Inhibitor for Treatment of Diabetic Kidney Disease [NA]

View source ↗

Summary

This clinical trial update discusses the maximal dose of an ACE inhibitor being studied for treating diabetic kidney disease, with the trial now completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus Type
• Diabetic Nephropathy

Drugs mentioned

• ACE inhibitor (angiotensin-converting enzyme inhibitor)

Snippet

Sponsor: Steno Diabetes Center Copenhagen | Conditions: Diabetes Mellitus, Type I, Diabetic Nephropathy | NA | Status: COMPLETED